Search

everythinglearnresearchcommunity

for

Search:↓

Oxidative stress increases in early hair loss, and family history plays a role; antioxidants may help future treatments.

The conclusion is that a combination of noninvasive treatments and lifestyle changes can improve skin health during menopause.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Finasteride doesn't affect oral testosterone undecanoate, and high DHT levels may cause acne, prostate issues, and hair loss.

Pregnancy with Cushing's syndrome is rare and risky for both mother and baby, needing early diagnosis and treatment.

Finasteride causes reduced tear flow and severe eye inflammation.

Cytochrome P-450 enzymes in the skin help break down various substances and could be targeted to treat skin conditions.

PRP treatment improves hair count, density, and reduces hair loss in AGA patients.

The conclusion is that hair loss in women is caused by a mix of hormonal, environmental, and genetic factors, and treatments should target these various causes.

A specific RNA molecule, circCOL1A1, affects the growth and quality of goat hair by interacting with miR-149-5p and influencing cell growth pathways.

5α-reductase inhibitors can interfere with doping tests by masking banned substances.

The Wnt signaling pathway is not a major factor in the development of keratoacanthoma, a type of skin tumor.

Finasteride affects offspring's antioxidant enzymes in epididymis, possibly disrupting sperm maturation.

Identifying nonclassic congenital adrenal hyperplasia and carriers of CYP21 mutations is challenging, and genetic counseling is recommended due to their prevalence.

TLR2 is important for hair growth and can be targeted to treat hair loss.

Skin aging reflects overall body aging and can indicate internal health conditions.

PSA could be a marker for hyperandrogenism in women, but more research is needed.

Current treatments for androgenetic alopecia manage symptoms but don't cure it, and it affects social and psychological well-being.

PCOS is linked to a higher risk of endometrial cancer but not ovarian or breast cancer, and more research is needed on its role in cancer development and treatment effects.

The document explains various skin conditions and their treatments.

Chrousos Syndrome is caused by mutations that make the body less sensitive to glucocorticoids, leading to various symptoms and requiring high-dose treatment.

Diabetes can cause a variety of skin disorders, some of which may signal more serious health issues.

Women with PCOS are much more likely to have sleep problems and should be checked for them.

Treatments for hair loss vary, but cell-based options may be the future.

The vitamin D receptor is crucial for bone health and affects various body systems, with mutations potentially leading to disease.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Removing part of the vitamin D receptor stops vitamin D from working properly.

Finasteride treats enlarged prostate and hair loss, but may cause side effects in some patients.

Inflammation may be linked to hair loss, and targeting specific enzymes could help treat it.

New targets for making and using brain-synthesized steroids could lead to better treatments for brain disorders and alcoholism.